The Board proposes the rule amendment to delete the PARE as the designated clinical competency examination due to the NABP discontinuing the examination.

 

DEPARTMENT OF HEALTH

Board of Pharmacy

RULE NO.: RULE TITLE:

64B16-26.200 Examination Requirements; Current Competency; Passing Scores

PURPOSE AND EFFECT: The Board proposes the rule amendment to delete the PARE as the designated clinical competency examination due to the NABP discontinuing the examination.

SUMMARY: The PARE will be deleted as the designated examination due to the NABP discontinuing the examination.

SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS AND LEGISLATIVE RATIFICATION:

The Agency has determined that this will not have an adverse impact on small business or likely increase directly or indirectly regulatory costs in excess of $200,000 in the aggregate within one year after the implementation of the rule. A SERC has not been prepared by the Agency.

The Agency has determined that the proposed rule is not expected to require legislative ratification based on the statement of estimated regulatory costs or if no SERC is required, the information expressly relied upon and described herein: During discussion of the economic impact of this rule at its Board meeting, the Board, based upon the expertise and experience of its members, determined that a Statement of Estimated Regulatory Costs (SERC) was not necessary and that the rule will not require ratification by the Legislature. No person or interested party submitted additional information regarding the economic impact at that time.

Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.

RULEMAKING AUTHORITY: 456.017(1), 465.005, 465.0075(1) FS.

LAW IMPLEMENTED: 456.017(1)(b), (6), 456.036(9), 465.007(3), 465.0075 FS.

IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN THE FAR.

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: C. Erica White, Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin C04, Tallahassee, Florida 32399-3254.

 

THE FULL TEXT OF THE PROPOSED RULE IS:

64B16-26.200 Examination Requirements; Current Competency; Passing Scores.

(1) No change.

(2) Current Clinical Competency Examination. The Board hereby establishes the Pharmacist Assessment for Remediation Evaluation (PARE) offered by the National Association of Boards of Pharmacy (NABP) as the Board’s examination to assess current clinical competency in the practice of pharmacy. The minimum passing scaled score shall be seventy-five percent (75%).

(2)(3) No change.

Rulemaking Authority 456.017(1), 465.005, 465.0075(1) FS. Law Implemented 456.017(1)(b), (6), 456.036(9), 465.007(3), 465.0075 FS. History–New 10-17-79, Amended 2-8-81, 6-22-82, 8-16-84, 4-30-85, Formerly 21S-12.01, Amended 5-6-86, Formerly 21S-12.001, Amended 1-10-93, Formerly 21S-26.200, 61F10-26.200, Amended 7-1-97, Formerly 59X-26.200, Amended 3-22-99, 1-11-05, 4-4-17,                                  .

 

NAME OF PERSON ORIGINATING PROPOSED RULE: Board of Pharmacy

NAME OF AGENCY HEAD WHO APPROVED THE PROPOSED RULE: Board of Pharmacy

DATE PROPOSED RULE APPROVED BY AGENCY HEAD: February 6, 2018

DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAR: March 7, 2018